Preoperative Drug Monitoring in Management of Patients with Hip Fracture on Treatment with Direct Oral Anticoagulants

References

• Andreas P, Diamantopoulos MH. Short- and long-term mortality in males and females with fragility Hip fracture in Norway. A population-based study. Clin Intervent Aging. 2013;2:817–823.
   Google Scholar
• Guzon-Illescas O, Perez Fernandez E, Crespí Villarias N, et al. Mortality after osteoporotic Hip fracture: incidence, trends, and associated factors. J Orthop Surg Res. 2019;14(1):203. PMID: 31272470; PMCID: PMC6610901. doi:10.1186/s13018-019-1226-6
   PubMed Web of Science ®Google Scholar
• Wu AM, Bisignano C, James SL, et al. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2021;2(9):e580–e592. doi:10.1016/S2666-7568(21)00172-0
   PubMedGoogle Scholar
• Veronese N, Maggi S. Epidemiology and social costs of Hip fracture. Injury. 2018;49(8):1458. doi:10.1016/j.injury.2018.04.015
   PubMed Web of Science ®Google Scholar
• Moja L. Timing matters in Hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS One. 2012;7:e461.
   Web of Science ®Google Scholar
• Haentjens P, Magaziner J, Colón-Emeric CS, et al. Meta-analysis: excess mortality after Hip fracture among older women and men. Ann Intern Med. 2010;152(6):380–390. doi:10.7326/0003-4819-152-6-201003160-00008
   PubMed Web of Science ®Google Scholar
• Wicklein S, Gosch M. Osteoporose und Multimorbidität [Osteoporosis and multimorbidity]. Z Gerontol Geriatr. 2019;52(5):433–439. doi:10.1007/s00391-019-01569-5
   PubMed Web of Science ®Google Scholar
• Leung F, Lau TW, Kwan K, Chow SP, Kung AW. Does timing of surgery matter in fragility Hip fractures? Osteoporos Int. 2010;21(S4):529–534. doi:10.1007/s00198-010-1391-2
   Google Scholar
• Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. 2019;179(11):1469‐1478. doi:10.1001/jamainternmed.2019.2431
   PubMed Web of Science ®Google Scholar
• Tran T, Delluc A, de Wit C, Petrcich W, Le Gal G, Carrier M. The impact of oral anticoagulation on time to surgery in patients hospitalized with Hip fracture. Thromb Res. 2015;136(5):962–965. doi:10.1016/j.thromres.2015.09.017
   PubMed Web of Science ®Google Scholar
• Taranu R, Redclift C, Williams P, et al. Use of anticoagulants remains a significant threat to timely hip fracture surgery. Geriatr Orthop Surg Rehabil. 2018;9:2151459318764150. doi:10.1177/2151459318764150
   Web of Science ®Google Scholar
• Mullins B, Akehurst H, Slattery D, Chesser T. Should surgery be delayed in patients taking direct oral anticoagulants who suffer a Hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre. BMJ Open. 2018;8(4):e020625. doi:10.1136/bmjopen-2017-020625
   PubMed Web of Science ®Google Scholar
• Schermann H, Gurel R, Gold A, et al. Safety of urgent Hip fracture surgery protocol under influence of direct oral anticoagulation medications. Injury. 2019;50(2):398–402. doi:10.1016/j.injury.2018.10.033
   PubMed Web of Science ®Google Scholar
• Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39:16.
   Google Scholar
• Halvorsen S, Mehilli J, Cassese S, et al.; ESC Scientific Document Group. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022;43(39):3826–3924. doi:10.1093/eurheartj/ehac270
   PubMed Web of Science ®Google Scholar
• Keeling D, Tait RC, Watson H; Haematology tBCoSf. Peri-operative management of anticoagulation and antiplatelet therapy. Br J Haematol. 2016;175(4):602–613. doi:10.1111/bjh.14344
   PubMed Web of Science ®Google Scholar
• Viktil K, Lehre I, Anette H. Ranhoff, Espen Molden, serum concentrations and elimination rates of Direct-Acting Oral Anticoagulants (DOACs) in Older hip fracture patients hospitalized for surgery: a pilot study. Drugs Aging. 2019;36:65. doi:10.1007/s40266-018-0609-4
   PubMed Web of Science ®Google Scholar
• Levy JH, Ageno W, Chan NC, Crowther M, Verhamme P, Weitz JI. Subcommittee on Control of Anticoagulation. When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(3):623–627. doi:10.1111/jth.13227
   PubMed Web of Science ®Google Scholar
• Pernod G, Albaladejo P, Godier A, et al; Working Group on Perioperative Haemostasis. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP). Arch Cardiovasc Dis. 2013;106(6–7):382–393. doi:10.1016/j.acvd.2013.04.009
   PubMed Web of Science ®Google Scholar
• Godier A, Dincq AS, Martin AC, et al. Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study. Eur Heart J. 2017;38(31):2431–2439. doi:10.1093/eurheartj/ehx403
   PubMed Web of Science ®Google Scholar
• Rostagno C, Buzzi R, Campanacci D, et al. In hospital and 3-month mortality and functional recovery rate in patients treated for hip fracture by a multidisciplinary team. PLoS One. 2016;11(7):e0158607. doi:10.1371/journal.pone.0158607
   PubMed Web of Science ®Google Scholar
• Borges FK, Bhandari M, Guerra-Farfan E; HIP ATTACK Investigators. Accelerated surgery versus standard care in Hip fracture (Hip ATTACK): an international, randomised, controlled trial. Lancet. 2020;395(10225):698–708. doi:10.1016/S0140-6736(20)30058-1
   PubMed Web of Science ®Google Scholar
• Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT. Regional Anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American society of regional anesthesia and pain medicine evidence-based guidelines (Fourth Edition). Reg Anesth Pain Med. 2018;43(3):263. doi:10.1097/AAP.0000000000000763
   PubMed Web of Science ®Google Scholar
• Aigner R, Buecking B, Hack J, et al. On Behalf of the registry for geriatric trauma atr-dgu. effect of direct oral anticoagulants on treatment of geriatric hip fracture patients: an analysis of 15,099 patients of the alters trauma register DGU®. Medicina. 2022;58(3):379. doi:10.3390/medicina58030379
   PubMedGoogle Scholar
• Leer-Salvesen S, Dybvik E, Ranhoff AH, et al. Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for Hip fracture patients? Eur Geriatr Med. 2020;11(4):563–569. doi:10.1007/s41999-020-00319-w
   PubMed Web of Science ®Google Scholar
• NHS England. Clinical guide for the perioperative care of people with fragility fractures during the Coronavirus pandemic; 2020. Available from: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/C0086_Specialty-guide.Fragility-Fracturesand-Coronavirus-v1-26-March. Accessed April 24, 2024.
   Google Scholar
• Aziz S, Almeida K, Taylor G. How should we manage Hip fracture patients on direct oral anticoagulants? BMJ Evidence Based Med. 2021;26(1):22–25. doi:10.1136/bmjebm-2019-111317
   PubMedGoogle Scholar
• Wall PV, Mitchell BC, Ta CN, Kent WT. Review of perioperative outcomes and management of Hip fracture patients on direct oral anticoagulants. EFORT Open Rev. 2023;8(7):561–571. doi:10.1530/EOR-22-0060
   PubMed Web of Science ®Google Scholar
• Orosz GM, Magaziner J, Hannan EL, et al. Association of timing of surgery for Hip fracture and patient outcomes. JAMA. 2004;291(14):1738–1743. doi:10.1001/jama.291.14.1738
   PubMed Web of Science ®Google Scholar